Literature DB >> 10536670

Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes.

E Delpy1, S N Hatem, N Andrieu, C de Vaumas, M Henaff, C Rücker-Martin, J P Jaffrézou, G Laurent, T Levade, J J Mercadier.   

Abstract

OBJECTIVES: Anthracyclines cause apoptotic death in many cell types through activation of the ceramide pathway. We tested the hypothesis that doxorubicin induces cardiac myocyte apoptosis through ceramide generation.
METHODS: Adult rat ventricular myocytes were grown in the presence of 10% fetal calf serum, and exposed to 0.5 microM doxorubicin (Dox) for 1 h on the day of cell isolation (day 0). We used the membrane-permeant ceramide analog C2-ceramide (C2-cer) to mimic the effects of endogenous ceramide and PDMP to induce endogenous ceramide accumulation. Apoptosis was assessed upon morphological criteria and DNA fragmentation by the TUNEL method and agarose gel electrophoresis. Ceramide concentration was assessed using the DAG kinase assay.
RESULTS: Myocyte exposure to Dox was associated with cellular and nuclear alterations typical of apoptosis on day 7 but not on day 3. At day 7, the percentage of TUNEL-positive myocytes was markedly increased in Dox-treated cultures compared to control (Cl) cultures (82 +/- 3 vs. 12 +/- 1%, n = 7; p < 0.001); internucleosomal DNA fragmentation was confirmed by the observation of DNA ladders. These alterations were associated with an increase in the intracellular ceramide concentration (1715 +/- 243 vs. 785 +/- 99 pmol/mg prot, n = 5; p < 0.01), a phenomenon also detected on day 3 (731 +/- 59 vs. 259 +/- 37 pmol/mg prot, n = 5; p < 0.001). Incubation of myocytes at day 0 with 50 microM C2-cer induced rapid cell shrinkage and DNA fragmentation (45 +/- 3 vs. 10 +/- 1% TUNEL-positive myocytes on day 1 in C2-cer-treated and Cl cultures, respectively; n = 6, p < 0.001). Myocyte exposure to 10 microM PDMP for 7 days (n = 5), caused ceramide accumulation (1.7-fold increase vs. Cl, p < 0.01), and a marked increase in the percentage of TUNEL-positive myocytes (62 +/- 6 vs. 11 +/- 3% in Cl cultures, p < 0.001). Ventricles of rats injected intraperitoneally with a cumulative dose of 14 mg/kg Dox over a period of 2 weeks also showed an increased ceramide concentration 2 weeks later (11.01 +/- 0.64 vs. 5.24 +/- 0.88 pmol/mg prot, n = 6; p < 0.001).
CONCLUSION: Our study confirms the existence of a functional ceramide pathway related to apoptosis in cardiac myocytes, and points to its possible involvement in doxorubicin-induced cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536670     DOI: 10.1016/s0008-6363(99)00142-x

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  23 in total

1.  Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.

Authors:  Qinglin Yang
Journal:  Cardiovasc Res       Date:  2007-02-12       Impact factor: 10.787

Review 2.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

3.  Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis.

Authors:  Jennifer Y Kong; Shaun S Klassen; Simon W Rabkin
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

4.  Chronic vascular toxicity of doxorubicin in an organ-cultured artery.

Authors:  T Murata; H Yamawaki; M Hori; K Sato; H Ozaki; H Karaki
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Increased de novo ceramide synthesis and accumulation in failing myocardium.

Authors:  Ruiping Ji; Hirokazu Akashi; Konstantinos Drosatos; Xianghai Liao; Hongfeng Jiang; Peter J Kennel; Danielle L Brunjes; Estibaliz Castillero; Xiaokan Zhang; Lily Y Deng; Shunichi Homma; Isaac J George; Hiroo Takayama; Yoshifumi Naka; Ira J Goldberg; P Christian Schulze
Journal:  JCI Insight       Date:  2017-05-04

Review 6.  Doxorubicin, DNA torsion, and chromatin dynamics.

Authors:  Fan Yang; Sheila S Teves; Christopher J Kemp; Steven Henikoff
Journal:  Biochim Biophys Acta       Date:  2013-12-19

7.  Insulin-like growth factor binding protein-3 mediates serum starvation- and doxorubicin-induced apoptosis in H9c2 cardiac cells.

Authors:  R Granata; M De Petrini; L Trovato; R Ponti; N Pons; C Ghè; A Graziani; R J Ferry; G Muccioli; E Ghigo
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

8.  Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death.

Authors:  Valentina Parra; Francisco Moraga; Jovan Kuzmicic; Camila López-Crisosto; Rodrigo Troncoso; Natalia Torrealba; Alfredo Criollo; Jessica Díaz-Elizondo; Beverly A Rothermel; Andrew F G Quest; Sergio Lavandero
Journal:  Biochim Biophys Acta       Date:  2013-04-16

9.  WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.

Authors:  Balachandar Venkatesan; Sumanth D Prabhu; Kaliyamurthi Venkatachalam; Srinivas Mummidi; Anthony J Valente; Robert A Clark; Patrice Delafontaine; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2010-01-13       Impact factor: 4.315

10.  A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis.

Authors:  Gauri A Patwardhan; Qian-Jin Zhang; Dongmei Yin; Vineet Gupta; Jianxiong Bao; Can E Senkal; Besim Ogretmen; Myles C Cabot; Girish V Shah; Paul W Sylvester; S Michal Jazwinski; Yong-Yu Liu
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.